SNGX Stock Quote Price and Forecast | CNN

SNGX

Soligenix, Inc.

Key terms

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Apr 17 11:00am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 15 7:32am ET Soligenix: FDA grants orphan drug designation for active ingredient in MarVax by TipRanks Apr 11 7:33am ET Soligenix confirms FDA orphan designation for active ingredient in SuVax by TipRanks Apr 08 6:12pm ET Soligenix prophylaxis against Sudan Ebola Virus gets FDA orphan designation by TipRanks Apr 08 6:08pm ET Soligenix prevention against Marburg marburgvirus gets FDA orphan designation by TipRanks Apr 03 7:34am ET Soligenix reaches agreement with EMA on second HyBryte trial by TipRanks Feb 08 7:37am ET Soligenix forms Medical Advisory Board for Behcet’s Disease by TipRanks

Nov 11 4:30am ET Investor Summit Group Announces Soligenix, Inc. To Present at Q4 Conference by NewsFile Oct 13 4:30am ET Soligenix Enters Q4 With Multiple Catalysts in Play by NewsFile Sep 12 4:30am ET FDA Awards $2.6 Million Grant for Expanded Study of Soligenix's Hybryte(TM) for CTCL by NewsFile Jul 26 5:27am ET Soligenix's HyBryte(TM) Treatment Now Within Reach for Rare Cancer Patients by NewsFile Jun 07 4:30am ET Soligenix Moves Forward with Treatments for Cutaneous T-Cell Lymphoma and Psoriasis by NewsFile Mar 01 10:04am ET Soligenix, Inc. to Present at the Q1 Virtual Investor Summit by NewsFile Jan 12 7:00am ET Soligenix Corporate Update Includes NDA Plans for HyBryte(TM) by NewsFile

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.

Frederic J. Brown/AFP/Getty Images

Oil prices get short-lived boost from attack on Iran

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)

Spencer Platt/Getty Images

US regional banks are still under pressure. That’s likely to continue

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.

Frank Franklin II/AP

Trump Media stock ends session 15% higher after two very bad days

Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.

Patrick Reddy/The Enquirer/AP/File

Private equity finds its next bet: college admissions